Showing 36 out of 97 results
Where is the balance now? Preliminary injunctions in pharmaceutical patent proceedings in 2020 and beyond
Recent decisions of the Federal Court of Australia have significantly changed the way in which parties to pharmaceutical patent litigation should analyse …
Herbert Smith Freehills’ finance team advises Crescent Capital Partners on acquisition of PRP Group
Herbert Smith Freehills has advised Crescent Capital Partners on the debt financing aspects of its acquisition of PRP Group. Crescent has been the most …
Future Cities Series: How planning and zoning rules can drive post-Covid development
The evolution of cities has long been defined by threats and crisis. Covid-19 will be no exception.The Covid-19 pandemic has spread rapidly in densely …
Herbert Smith Freehills advises Healius on the sale of its medical and dental centres business
Herbert Smith Freehills’ M&A team has advised Healius Limited on the sale of its medical and dental centres business, with an enterprise value of …
Calls for increased domestic pharmaceutical production not warranted, say Herbert Smith Freehills experts
Increased commentary about Australia’s perceived vulnerability to pharmaceutical shortages have led to recent calls for an overhaul of the country’s …
Manufacturing medicines in Australia: examining the need for increased domestic capability
There has been much discussion about the need for Australia to increase “sovereign capability” in domestic pharmaceutical manufacturing. …
Herbert Smith Freehills advises Ramsay Health Care Limited on its capital raising
Herbert Smith Freehills has advised Ramsay Health Care Limited (Ramsay Health Care) on its capital raising, comprising a fully underwritten A$1,200 …
Commonwealth fails in its claim for compensation for PBS expenditure
The Federal Court’s decision in Commonwealth v Sanofi Justice Nicholas’ long-awaited decision in Commonwealth v Sanofi is an Australian first.1 Of the 4 …
COVID-19: People: Contact Tracing – balancing civil liberties (Australia)
In considering all its defensive options against the spread of COVID-19, the Australian Government has proposed a contact tracing smartphone “app” to be …
A General Safety Provision - are we there yet??
It is looking increasingly likely that a ‘General Safety Provision’ for consumer products will be introduced into legislation in the near future. This …
Directors and ESG disclosure – The risks will only get bigger
With activist investors and NGOs prowling, firms making flimsy ethical claims will increasingly end up in courtIn the context of BlackRock’s climate …
Australian privacy law reform and review announced
On 12 December 2019, the Australian Government announced its response to the Australian Competition & Consumer Commission’s (ACCC) Digital Platform …
Showing 36 out of 97 results
View more